Information Letter on Actilyse® powder and solvent for solution for injection and infusion (alteplase) for acute ischaemic stroke: important extension of indication to include adolescents under 16 years of age
2018.06.22
Active substance: alteplase
Actilyse® has been licensed for treatment of acute ischaemic stroke in adolescent patients under 16 years of age.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN